✦ LIBER ✦

Hereditary thrombophilia and fetal loss: a prospective follow-up study

✍ Scribed by C. Y. Vossen; F. E. Preston; J. Conard; J. Fontcuberta; M. Makris; F. J. M. Van Der Meer; I. Pabinger; G. Palareti; I. Scharrer; J. C. Souto; P. Svensson; I. D. Walker; F. R. Rosendaal

Book ID: 109148303
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 104 KB
Volume: 2
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2004.00662.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hereditary thrombophilia as a cause of f

Hereditary thrombophilia as a cause of fetal loss

✍ Celeste P. Durnwald; Robert Flora; Dimitri Agamanolis; Nicholas Spirtos; Mark St 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 117 KB

Fetal Ureteric Reflux: A Follow–up Study

✍ J. E. S. SCOTT 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

Genetic anticipation and breast cancer:

Genetic anticipation and breast cancer: a prospective follow‐up study

✍ Andrew D. Paterson; David M.J. Naimark; Jian Huang; Celine Vachon; Arturas Petro 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 77 KB

Prognosis in Childhood Epilepsy: A Prosp

Prognosis in Childhood Epilepsy: A Prospective Follow-Up Study

✍ Shunsuke Ohtahara; Yasuko Yamatogi; Yoko Ohtsdca; Eiji Oka; Soichiro Kanda 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 869 KB

Mild dilatation of the fetal kidney: a f

Mild dilatation of the fetal kidney: a follow-up study

✍ D.F.M. THOMAS; N.P. MADDEN; H.C. IRVING; R.J. ARTHUR; S.E.W. SMITH 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 863 KB

Psychological consequences of predictive

Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A prospective follow-up study

✍ Katja Aktan-Collan; Ari Haukkala; Jukka-Pekka Mecklin; Antti Uutela; Helena Käär 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 1 views

Predictive genetic testing for cancer allows identification of those with the mutation (mutation positive) who should undergo cancer surveillance aiming at early detection of cancer and those without the mutation (mutation negative), whose unnecessary worry can be alleviated and who need not undergo